ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Government agencies at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

15 government agencies are at ACR Convergence 2026 — 60 presentations on the program and 1 with a booth in the exhibit hall. Most represented: National Institute of Arthritis and Musculoskeletal and Skin Diseases (11 on the program), National Institutes of Health (11 on the program), Food and Drug Administration (5 on the program). As of Nov 2, 2026.

All 1,101 organizations at ACR Convergence 2026 →

Topic
Top represented
Showing 1–5 of 15 organizations
OrganizationACR Convergence 2026 Attendance
Government agencies
Federal institute supporting research on arthritis, musculoskeletal and skin diseases.
Talk
Sun Nov 8
9:00am–9:30am
Part of Decoding Myositis: From Mechanism to Medicine
Autoantibodies and Immune Phenotyping in Inflammatory Myositis
W206
Myositis
Talk
Sun Nov 8
1:00pm–1:15pm
Part of Adult Thieves Market: Show Me Your Best Cases!
Case 1
W304A-H
Education and careers
Session
Sun Nov 8
1:00pm–2:30pm
Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology? Session 1
Hall B, WB3 and WB4
Treatment safety · with Arthritis and Pain Associates of Prince George's County, University of Washington
  1. 1:00pmCARs, TCEs, and Newer MAbs: Fundamental Science of Cellular TherapiesFriedrich-Alexander-Universität Erlangen-Nürnberg
  2. 1:35pmPotential Side Effects of Cellular Therapies: ICAN Be Aware of These Potentially CRiouS IssuesHospital for Special Surgery
  3. 1:55pmFundamentals of Teaching Immunology to Trainees and Helping Them Communicate These Concepts to PatientsSwedish Medical Center/Providence St. Joseph Health
Talk
Sun Nov 8
3:00pm–3:30pm
Part of Friendly Fire: Breaking Tolerance in the Cardiovascular System
Guardians Turned Foes: Innate Immune Players in Cardiovascular Disease
W204
Immunology
Poster
Mon Nov 9
10:30am–12:30pm
Session
Mon Nov 9
1:00pm–2:00pm
When the Message Changes: Nucleic Acid Modifications in Rheumatic Disease
W204
Immunology
  1. 1:00pmThe Role of Nucleic Acids in Autoimmunity in FibrosisHospital for Special Surgery
  2. 1:30pmRegulation of Cryptic Splicing and the Implications in AutoimmunityBaylor College of Medicine
Session
Tue Nov 10
8:30am–9:30am
Beyond CD19: The Next Frontier in Engineered T-Cell Targets
W204
Treatment safety · with Johns Hopkins University
  1. 8:30amStromal Targets for CAR-T CellsUniversity of Birmingham
  2. 9:00amAdvancing Antigen Specific Therapy Through T Cell EngineeringBenaroya Research Institute at Virginia Mason
Poster
Tue Nov 10
10:30am–12:30pm
Government agencies
A U.S. federal agency that supports and conducts biomedical research.
Booth
Exhibiting at Booth 4715-NP
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Talk
Sat Nov 7
8:10am–8:55am
Part of Basic & Clinical Research Conference
Keynote Address: Using AI and Big Data for Biomedical Discovery and Clinical Impact
W415D
Education and careers
Poster
Sun Nov 8
10:30am–12:30pm
Talk
Tue Nov 10
8:30am–9:00am
Part of Untangling the Genetic Drivers of Autoinflammation
Expanding the Genetic Causes of Autoinflammation
W311A-D
Genetics and genomics
Poster
Tue Nov 10
10:30am–12:30pm
Session
Wed Nov 11
8:00am–9:00am
Decoding the Exposome: Integrated Methods and Interdisciplinary Teams
W415D
Immunology · with Emory University
  1. 8:00amDecoding the Exposome: Integrated Methods and Interdisciplinary TeamsEmory University
  2. 8:30amDecoding the Exposome: Integrated Methods and Interdisciplinary TeamsMedical University of South Carolina
Government agencies
U.S. federal agency responsible for regulating food, drugs, biologics, and medical devices.
Session
Sun Nov 8
3:30pm–5:00pm
2026 Rheumatology Update from the FDA
Hall B, WB3 and WB4
Epidemiology and outcomes · with Stanford University, University of Washington, Boston Children's Hospital
  1. 3:30pmNew Approvals in Rheumatology; An Exciting Year.Food and Drug Administration
  2. 3:55pmReview of Recent FDA Conference on Pediatric SLEFood and Drug Administration
  3. 4:20pmNew Safety Issues Identified in the Last Year in Adult RheumatologyFood and Drug Administration
Talk
Sun Nov 8
3:30pm–3:55pm
Part of 2026 Rheumatology Update from the FDA
New Approvals in Rheumatology; An Exciting Year.
Hall B, WB3 and WB4
Education and careers
Talk
Sun Nov 8
3:55pm–4:20pm
Part of 2026 Rheumatology Update from the FDA
Review of Recent FDA Conference on Pediatric SLE
Hall B, WB3 and WB4
Education and careers
Talk
Sun Nov 8
4:20pm–4:45pm
Part of 2026 Rheumatology Update from the FDA
New Safety Issues Identified in the Last Year in Adult Rheumatology
Hall B, WB3 and WB4
Education and careers
Talk
Mon Nov 9
1:20pm–1:40pm
Part of Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology? Session 2
Regulatory Issues and Cellular Therapy: FDA Overview
Hall B, WB3 and WB4
Treatment safety
Government agencies
The NIH institute that leads genomics research and its translation into medicine.
Poster
Mon Nov 9
10:30am–12:30pm
Poster
Mon Nov 9
10:30am–12:30pm
Talk
Tue Nov 10
9:00am–9:30am
Part of A NOD '2' Change: A Model Gene Linking Inborn Errors of Immunity to Rheumatic Disease
Potential Immunogenetic Mechanisms Linking NOD2 Low-Penetrance or Risk Variants and Chronic Disease
W110A
Rare and other diseases
Government agencies
A U.S. government institute that conducts and supports environmental health research.
Talk
Tue Nov 10
1:00pm–1:30pm
Part of Context Matters - Environmental Tuning of Immune and Autoimmune Responses
Rise in Autoimmunity and Autoimmune Diseases and the Role of Environmental and Lifestyle Factors
W110A
Immunology
Session
Tue Nov 10
4:00pm–5:00pm
50 years of Progress and Hope for Pediatric Rheumatic Disorders, Using Juvenile Myositis as an Exemplar to Celebrate Scientific Advancement
W414
Myositis · with University of Michigan, Riley Hospital for Children
  1. 4:00pm50 years of Progress and Hope for Pediatric Rheumatic Disorders, Using Juvenile Myositis as an Exemplar to Celebrate Scientific AdvancementUniversity College London

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from government agencies

Tell us what you sell and we’ll find the people at these government agencies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ACR Convergence 2026 by

Exhibit hall

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction